Paper39598451
Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis.
Morgan GJ and 4 others. Pharmaceuticals (Basel), 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis. Papers, record 39598451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39598451
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R25 HL118693 | NHLBI NIH HHS | United States | R25HL118693 | PubMed and NIH | NIH RePORTER |
| 2R25HL118693-11A1 | NIH HHS | United States | R25HL118693 | PubMed and NIH | NIH RePORTER |
| 1UL1TR001430-07S1 | NIH HHS | United States | UL1TR001430 | PubMed and NIH | NIH RePORTER |
| P01 HL068705 | NHLBI NIH HHS | United States | P01HL068705 | PubMed | NIH RePORTER |
| UL1 TR001430 | NCATS NIH HHS | United States | UL1TR001430 | PubMed and NIH | NIH RePORTER |
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21495850 | Protein folding and modification in the mammalian endoplasmic reticulum. | Annu Rev Biochem | 2011 | https://conductscience.org/library/papers/21495850 | PubMed |
| 2 | 30894521 | Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient. | Nat Commun | 2019 | https://conductscience.org/library/papers/30894521 | PubMed |
| 3 | 30894526 | Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis. | Nat Commun | 2019 | https://conductscience.org/library/papers/30894526 | PubMed |
| 4 | 34655133 | Observed Antibody Space: A diverse database of cleaned, annotated, and translated unpaired and paired antibody sequences. | Protein Sci | 2022 | https://conductscience.org/library/papers/34655133 | PubMed |
| 5 | 30760926 | High frequency of shared clonotypes in human B cell receptor repertoires. | Nature | 2019 | https://conductscience.org/library/papers/30760926 | PubMed |
| 6 | 39069558 | Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis. | Nat Commun | 2024 | https://conductscience.org/library/papers/39069558 | PubMed |
| 7 | 34741031 | Role of mutations and post-translational modifications in systemic AL amyloidosis studied by cryo-EM. | Nat Commun | 2021 | https://conductscience.org/library/papers/34741031 | PubMed |
| 8 | 31097697 | Kappa chain maturation helps drive rapid development of an infant HIV-1 broadly neutralizing antibody lineage. | Nat Commun | 2019 | https://conductscience.org/library/papers/31097697 | PubMed |
| 9 | 37516426 | The Cryo-EM STRUCTURE of Renal Amyloid Fibril Suggests Structurally Homogeneous Multiorgan Aggregation in AL Amyloidosis. | J Mol Biol | 2023 | https://conductscience.org/library/papers/37516426 | PubMed |
| 10 | 39350582 | Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. | Amyloid | 2024 | https://conductscience.org/library/papers/39350582 | PubMed |
| 11 | 11549845 | Nomenclature of the human immunoglobulin kappa (IGK) genes. | Exp Clin Immunogenet | 2001 | https://conductscience.org/library/papers/11549845 | PubMed |
| 12 | 38879609 | Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis. | Nat Commun | 2024 | https://conductscience.org/library/papers/38879609 | PubMed |
| 13 | 32878258 | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions. | Biomedicines | 2020 | https://conductscience.org/library/papers/32878258 | PubMed |
| 14 | 1582976 | Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. | Hematol Oncol Clin North Am | 1992 | https://conductscience.org/library/papers/1582976 | PubMed |
| 15 | 35610346 | An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis. | Leukemia | 2022 | https://conductscience.org/library/papers/35610346 | PubMed |
| 16 | 19291508 | AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences. | Amyloid | 2009 | https://conductscience.org/library/papers/19291508 | PubMed |
| 17 | 32211238 | Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease. | PeerJ | 2020 | https://conductscience.org/library/papers/32211238 | PubMed |
| 18 | 20194151 | Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma. | Mayo Clin Proc | 2010 | https://conductscience.org/library/papers/20194151 | PubMed |
| 19 | 23451869 | Systemic amyloidoses. | Annu Rev Biochem | 2013 | https://conductscience.org/library/papers/23451869 | PubMed |
| 20 | 32594098 | N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression. | Leukemia | 2020 | https://conductscience.org/library/papers/32594098 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42482306 | Glycosylation penetrance of N-X-S/T sequons in antibody variable domains: a structural survey of 19,265 human antibody structures reassessing the histidine/glutamine suppression hypothesis. | MAbs | 2026 | https://conductscience.org/library/papers/42482306 | PubMed |
| 42278643 | Multiple Myeloma Concomitant with AL Amyloidosis: Histopathological Aspects of the Common Plasma Cell Spectrum. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278643 | PubMed |
| 40861476 | Clone-specific residue changes at multiple positions are associated with amyloid formation by antibody light chains. | Front Immunol | 2025 | https://conductscience.org/library/papers/40861476 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39598451
GET https://conductscience.org/api/papers/v1/39598451/references?page=2